Since the COVID-19 virus entered the world stage one year ago, it has been a consistent point of interest in the daily news. This notoriety can make it easy to forget the virus that used to dominate the news: Influenza. The Northern Hemisphere is experiencing unusually low flu activity for this time of year. And… Read more about COVID-19 Restrictions Contributes to a Light Flu Season
New SARS-CoV-2 Strain Found in Northern Europe’s Mink Population On November 5, 2020, Denmark reported 12 human cases of COVID-19 caused by a mutated SARS-CoV-2 strain carried by minks. Minks are a semi-aquatic mammal closely related to the weasel, otter, and ferret. Six other countries have reported outbreaks at mink farms including the Netherlands, Spain,… Read more about COVID-19 Update: Mutated Strain Found in Minks
As of September 17, 2020, there are over 29.9 million COVID-19 cases and 941,000 deaths worldwide. The United States leads the count with over 6.65 million cases and 197,000 deaths. The influential model from the Institute for Health Metrics and Evaluation projects there could be approximately 415,000 COVID-19 deaths by January 1, 2021 in the… Read more about Flu Season & the Pandemic: Twindemic or a Manageable Crisis?
Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Read more about COVID-19 Update: The Race for a Vaccine
As the US topped a whopping 2.8 million cases and a death count of 130,000 last week, cities and towns across the nation canceled July 4th firework displays and large public gatherings in an effort to prevent further spread of COVID-19. The fervor for holiday travel was scaled down this past weekend compared to prior… Read more about COVID-19 Update: The Disparity Between the US and the EU COVID-19 Experience
Once the epicenter of the virus outbreak, the densely populated city of New York endured months of significantly high rates of confirmed infections and reported deaths. As cases began to steadily decrease in the month of May, Governor Cuomo’s daily televised briefs became cautiously more hopeful. As we march towards the official start of summer… Read more about COVID-19 Update: What is the New Normal for Businesses?
Serological testing, also known as antibody testing, is a critical element of discussion when determining how and when the country will reopen. The process requires a blood sample to detect the presence of neutralizing antibodies (IgM, IgG) against a microorganism. Serological antibody tests are unlike polymerase chain reaction (PCR) diagnostic tests as the latter specifically… Read more about Coronavirus Update: Serological Testing